How Entrepreneurs Should Tackle Acquiring Investment with KdT Ventures Founder Dr Cain McClary
Dr. Cain McClary is the founder and managing director of KdT Ventures, a company that helps entrepreneurs start other businesses through early stage capital funding in the fields of life sciences innovation and technology. Cain has personally made first money investments in firms such as Zymergen, …
Inspiring, Hilarious, and Informative Highlights with Real Entrepreneurs
On the Supportedly podcast, I always need to cut material from interviews that I wish I could include in the podcast. This material is often packed with valuable insight, tips, and funny stories from inspiring entrepreneurs - like you - but needed to be cut for time.
On this bonus episode, I wa…
Leaders on a Mission - Cain McClary, Founder & Managing Partner, KdT Ventures, Episode 35
In this week’s episode I am joined by Cain McClary, Founder and Managing Partner of KdT ventures, an early stage investor, deploying capital across deep tech and life sciences. Cain speaks candidly about his life’s journey, from physician/scientist, with a deep passion for innovative technology and…
The World in a Grain of Sand: Editas
KdT Ventures Partners, Mack Healy & Cain McClary take a deep dive into a specific S-1 filing from a company that has or is hoping to go public within the biology realm. This month, Editas.
The World in a Grain of Sand: Royalty Pharma
KdT Ventures Partners, Mack Healy & Cain McClary take a deep dive into a specific S-1 filing from a company that has or is hoping to go public within the biology realm. This month, Royalty Pharma.
The World in a Grain of Sand: CG Oncology
KdT Ventures presents The World in a Grain of Sand, where we break down an S1 from a recent biotech IPO and share insights on the science, business models, and financials. In this episode, Cain McClary and Phil Grayeski discuss CG Oncology, the first biotech IPO of 2024. We dive into:
The vari…
The World in a Grain of Sand: BioAge
KdT Ventures presents The World in a Grain of Sand, where we break down an S1 from a recent biotech IPO and share insights on the science, business models, and financials. In this episode, Cain McClary and Phil Grayeski discuss BioAge, a longevity biotech with a pipeline of therapies for diseases o…
Episode 5: KdT Ventures' Founder and Managing Partner Cain McClary
He describes this path to venture investing from his start in science at the NIH to becoming a pathologist, and eventually raising a modest first fund and building off of its success. Plus, his investment philosophy and investing in science - including outside of therapeutics.
Episode 115: Exploring New Frontiers of Biotech and Healthcare Innovation Through Curiosity and Connection
What does the future of biotech look like when curiosity, not competition, leads the way?
In this episode, host Elaine Hamm, PhD, talks with Aziz Abadsafian, MBA, Technology Scout at Nissan Chemical America. Together, they dive into the “edges” of science — the more speculative world of embryology…
Episode 148: How AI, Supply Chains, and Smart Strategy are Redefining Biotech Investment and Venture Capital (RE-RELEASE)
How can biotech startup founders navigate the intersection of science, technology, and data to build truly durable companies?
In this episode, host Elaine Hamm, PhD, talks with Cain McClary, MD, Founder and Managing Partner of KdT Ventures, a seed-stage venture firm investing at the convergence of …
ポッドキャスト検索エンジン
当社の Web サイトを使用して、人、場所、トピックごとに 3,823,979 ポッドキャストや 195,701,402 エピソードを検索できます。
知識への投資は最も大きな利益をもたらす。だから私はポッドキャストを聴く。
‐ Benjamin "Llamacorn" Franklin
